EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS012-12888 
Organism
Homo sapiens 
Tissue/cell
Caco-2 
Coordinate
chr14:23029270-23031160 
TF binding sites/motifs
Number: 3             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
BCL6BMA0731.1chr14:23029337-23029354TTAATTCATGGTAAGCA-6.02
GATA2MA0036.3chr14:23029949-23029960GAAGATAAGAA-6.02
KLF16MA0741.1chr14:23031022-23031033GGGGGCGTGTC-6.32
Number of super-enhancer constituents: 30             
IDCoordinateTissue/cell
SE_10438chr14:23029283-23032250CD19_Primary
SE_11094chr14:23017827-23040557CD20
SE_11816chr14:23012773-23039979CD3
SE_14393chr14:22996582-23032363CD4_Memory_Primary_7pool
SE_15390chr14:23029166-23032172CD4_Memory_Primary_8pool
SE_15825chr14:23029585-23032234CD4_Naive_Primary_7pool
SE_16284chr14:23029113-23032359CD4_Naive_Primary_8pool
SE_16851chr14:23028955-23032314CD4p_CD225int_CD127p_Tmem
SE_17760chr14:22952943-23040457CD4p_CD25-_CD45ROp_Memory
SE_18236chr14:22973844-23040323CD4p_CD25-_Il17-_PMAstim_Th
SE_19107chr14:22988314-23032287CD4p_CD25-_Il17p_PMAstim_Th17
SE_19974chr14:23017747-23040104CD56
SE_20750chr14:23029024-23031885CD8_Memory_7pool
SE_21461chr14:23028855-23032323CD8_Naive_7pool
SE_21914chr14:22982456-23039590CD8_Naive_8pool
SE_22286chr14:22967300-23040267CD8_primiary
SE_26146chr14:23028931-23034596Duodenum_Smooth_Muscle
SE_30894chr14:23017778-23040632Fetal_Thymus
SE_32174chr14:23028831-23032277Gastric
SE_32456chr14:23028991-23039397GM12878
SE_39458chr14:23028949-23031230Jurkat
SE_50116chr14:23028808-23031991Sigmoid_Colon
SE_52479chr14:23028897-23031480Small_Intestine
SE_54170chr14:23029361-23032005Spleen
SE_55091chr14:23028901-23030369Thymus
SE_55091chr14:23030411-23031479Thymus
SE_60398chr14:22937960-23040268DHL6
SE_60958chr14:22933135-23040204HBL1
SE_62199chr14:22932483-23040287Tonsil
SE_66330chr14:23028949-23031230Jurkat
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr142302938723029658
Enhancer Sequence
CTTCCCTAAT GGAATTTAAG GCTCAGAAAG TGAGGCGCCT TGTCCGTTCT GATCATTTCT 60
GTAGCACTTA ATTCATGGTA AGCAAAAATT TAAAGGAAGG AGTAATAACA GAAAGAATGA 120
GCTCTGCCAT CAGATGTCTC TTATTTATAC CCTGACACTA GATTGGGGTT AAATGTTGAC 180
AATCATTGAA GCTGTTAGAC ATATGGGAGC TTGCTGGCCT CTTGACGTGC ATGTATACGC 240
AGGCATGAGG GAAAATTTCA ATTAAAAGTT AAAAACAAAG TTGTTTATCC CTGGGATTTA 300
ACAGGCCTGA ATAGCAGGTC TCAAACGGGG CTCCTAGGGA GGTCTCTCCG CTTCTCCCAG 360
GAAGAGCCAG GCCTGCCATT GGTCACCACA GTGCTTTAGC TGAAAGTCAG TGAAACGGAT 420
GTGCAGCTGA GGGAGAAAAG CAGTATGTCA TGGAACCCTC AGAGCTTCTG GTGAGCACTG 480
AAAGGAATGA TACATTTGTA GAGCAATTAC ATTCAGATAT TTTCACTTAA CGTTTTGTTG 540
GGATAACCAC AGTATGAAGT ATTATTATCC CCATGCTGAG TTTATGACTT ATCTCATTCA 600
AAGCGTAACC CAAACGCTTT CAGCTAGACA GAAATAAGAT TCAAGCCTAA CACTTGCTGA 660
GTCTCCATTT CCTCATCAGG AAGATAAGAA TGCCACCCAC CTCCTTCATG CAATGATAGG 720
GAAACGCAAG TAACAGGAGG GCGCTTAACA GTTTGCCAGA CATGTGGCCC ACGCTCGCTC 780
ACTCCTGGAC AGGATAGGGC TGTGTCTTAT CTTTTCTAAT GCCATGCACT ACCTAGCACA 840
GAGCCTAAGT GTGTAATTAT TTGCTAAATT TTAGCGACAA AAGGTCAACA GACAGTAAGT 900
GGCAGAACAA GTCCTTGAAT CAACACTTTC AGATCAAAGT GTTTTCCGCA ACACCAGGCT 960
GCCTCTCTGG TGGTTTGAAA ATACTTTTTA AAAATCCCAT TGACAGAACT TGGACCTACC 1020
TATAAAATCA ATGTAAGCAA ATAAAATACT TTGTTTAGTC CTTCTTCATA AGCTTCCTCC 1080
CACTTTTTTC CTACTCTCTC CTCTAAGATC CTTGTTCTAG AAAGTGTTTT CTCCCACAGG 1140
AGAAATCTAT TTTTTATATT TGTTAAAAAC TTTTAAATTA ACCGTAGTTA TTAAGTCATT 1200
TCACACACAA ACTTTTATTA CAGACGCCCA GAGCTGAGCT GCAACCCAAC AAGATAGGAG 1260
AGCAGCAGAG TCTCCCGCTA AGTTTGCAAA CAAGCTCCCT GGCCTCTATA ACCTCCAACA 1320
CCAGGGAGCA CGCCTCTGTG ACCTCCCCAA GTATTTTCTA GCCATCACAA CAAAAGTGTT 1380
TTGAAGCCCA AGATGAAATG ATGTGATCAC AAGAGGCCGA AGGTATAGGC TGCTAAGAGA 1440
AGAAAACAAG AGAGATGGTT TCCATGTGAT AGGGGCCAGG AAATGTGTGG GCAGGAGGTG 1500
CTCAGGGCTG GGCTTCCCAC CACTGCAAAG AATGGCAGGG AATAGACTTT CCACAGTGTT 1560
TGTGGTGAAT GGCTTCCGGC CCCATAAAAG AGCACAGAAA ATAAAAATAA ACCACCCCAT 1620
AGAGGTGTTG AGCAAGGGGG AGCAGGAAAT GCTAGGGTCT ACCTCACTCT CCATGCAGTA 1680
GTACTCAAAA TCAACTCCTT CAACATACTT CAGCTGAAAA AACACCTAAG AATCAGAAAC 1740
GCAATGGGGC TTGGGGGCGT GTCTTTAAGT TCAAGACAGG GTCTTGTTCT GTTGCCCAGA 1800
CTGAAGCGCA GTGGTGCAAT CATGCAGTCT CTACCTCCTG GGATCAAGTG ACTCTCCAAA 1860
CTCAGCCTCC CGAGTAGCTG GGACTACAGA 1890